Log In
Print
BCIQ
Print
Print this Print this
 

ATL1103

  Manage Alerts
Collapse Summary General Information
Company Antisense Therapeutics Ltd.
DescriptionSecond-generation antisense inhibitor of growth hormone receptor expression
Molecular Target Growth hormone receptor
Mechanism of ActionAntisense therapy
Therapeutic ModalityNucleic acid: Linear RNA: Antisense
Latest Stage of DevelopmentPhase II
Standard IndicationAcromegaly
Indication DetailsTreat acromegaly
Regulatory Designation

Partner

Isis Pharmaceuticals Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today